APO Research
Talk to an analyst

APO RESEARCH · REPORT

Total Artificial Heart

Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.

Selected research

Market Outlook & Growth Opportunities

Global Total Artificial Heart Market Outlook and Growth Opportunities 2026

9 January 2026199 pages

Choose your research edition.

Industry ResearchTotal Artificial Heart Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Total Artificial Heart Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Total Artificial Heart Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Total Artificial Heart Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Total Artificial Heart Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.

Global Total Artificial Heart key players include only SynCardia, with a share about 100%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 40 percent. In terms of product, SynCardia is the largest segment, with a share about 100%. And in terms of application, the largest application is Ischemic Cardiomyopathy, followed by Dilated Cardiomyopathy, etc.

This report provides an overview of the global Total Artificial Heart market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Total Artificial Heart and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Total Artificial Heart sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Total Artificial Heart market size, projected growth trends, production technologies, key applications, and end-use industries.

Total Artificial Heart Segment by Company

BiVACOR

SynCardia

Jarvik Heart

CARMAT

AbioMed

Total Artificial Heart Segment by Type

SynCardia

Others

Total Artificial Heart Segment by Application

Dilated Cardiomyopathy

Ischemic Cardiomyopathy

Others

Total Artificial Heart Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Total Artificial Heart status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Total Artificial Heart market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Total Artificial Heart significant trends, drivers, influence factors in global and regions.

6. To analyze Total Artificial Heart competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Total Artificial Heart market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Total Artificial Heart and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Total Artificial Heart.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Total Artificial Heart market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Total Artificial Heart industry.

Chapter 3: Detailed analysis of Total Artificial Heart manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Total Artificial Heart in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Total Artificial Heart in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Total Artificial Heart Industry Trends Table 2. Total Artificial Heart Industry Drivers Table 3. Total Artificial Heart Industry Opportunities and Challenges Table 4. Total Artificial Heart Industry Restraints Table 5. Global Total Artificial Heart Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Total Artificial Heart Revenue Share by Company (2021-2026) Table 7. Global Total Artificial Heart Sales Volume by Company (Units) & (2021-2026) Table 8. Global Total Artificial Heart Sales Volume Share by Company (2021-2026) Table 9. Global Total Artificial Heart Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Total Artificial Heart Company Ranking, (2024-2026) & (USD Million) Table 11. Global Total Artificial Heart Key Company Manufacturing Base & Headquarters Table 12. Global Total Artificial Heart Company, Product Type & Application Table 13. Global Total Artificial Heart Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Total Artificial Heart by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of SynCardia Table 18. Significant Companies of Others Table 19. Global Total Artificial Heart Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Total Artificial Heart Sales Volume by Type (2021-2026) & (Units) Table 21. Global Total Artificial Heart Sales Volume by Type (2027-2032) & (Units) Table 22. Global Total Artificial Heart Sales Volume Share by Type (2021-2026) Table 23. Global Total Artificial Heart Sales Volume Share by Type (2027-2032) Table 24. Global Total Artificial Heart Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Total Artificial Heart Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Total Artificial Heart Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Total Artificial Heart Sales Value Share by Type (2021-2026) Table 28. Global Total Artificial Heart Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Dilated Cardiomyopathy Table 30. Significant Companies of Ischemic Cardiomyopathy Table 31. Significant Companies of Others Table 32. Global Total Artificial Heart Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 33. Global Total Artificial Heart Sales Volume by Application (2021-2026) & (Units) Table 34. Global Total Artificial Heart Sales Volume by Application (2027-2032) & (Units) Table 35. Global Total Artificial Heart Sales Volume Share by Application (2021-2026) Table 36. Global Total Artificial Heart Sales Volume Share by Application (2027-2032) Table 37. Global Total Artificial Heart Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Total Artificial Heart Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Total Artificial Heart Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Total Artificial Heart Sales Value Share by Application (2021-2026) Table 41. Global Total Artificial Heart Sales Value Share by Application (2027-2032) Table 42. Global Total Artificial Heart Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 43. Global Total Artificial Heart Sales by Region (2021-2026) & (Units) Table 44. Global Total Artificial Heart Sales Market Share by Region (2021-2026) Table 45. Global Total Artificial Heart Sales by Region (2027-2032) & (Units) Table 46. Global Total Artificial Heart Sales Market Share by Region (2027-2032) Table 47. Global Total Artificial Heart Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Total Artificial Heart Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Total Artificial Heart Sales Value Share by Region (2021-2026) Table 50. Global Total Artificial Heart Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Total Artificial Heart Sales Value Share by Region (2027-2032) Table 52. Global Total Artificial Heart Market Average Price (USD/Unit) by Region (2021-2026) Table 53. Global Total Artificial Heart Market Average Price (USD/Unit) by Region (2027-2032) Table 54. Global Total Artificial Heart Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 55. Global Total Artificial Heart Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Total Artificial Heart Sales by Country (2021-2026) & (Units) Table 57. Global Total Artificial Heart Sales Market Share by Country (2021-2026) Table 58. Global Total Artificial Heart Sales by Country (2027-2032) & (Units) Table 59. Global Total Artificial Heart Sales Market Share by Country (2027-2032) Table 60. Global Total Artificial Heart Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Total Artificial Heart Sales Value Market Share by Country (2021-2026) Table 62. Global Total Artificial Heart Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Total Artificial Heart Sales Value Market Share by Country (2027-2032) Table 64. BiVACOR Company Information Table 65. BiVACOR Business Overview Table 66. BiVACOR Total Artificial Heart Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 67. BiVACOR Total Artificial Heart Product Portfolio Table 68. BiVACOR Recent Development Table 69. SynCardia Company Information Table 70. SynCardia Business Overview Table 71. SynCardia Total Artificial Heart Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 72. SynCardia Total Artificial Heart Product Portfolio Table 73. SynCardia Recent Development Table 74. Jarvik Heart Company Information Table 75. Jarvik Heart Business Overview Table 76. Jarvik Heart Total Artificial Heart Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. Jarvik Heart Total Artificial Heart Product Portfolio Table 78. Jarvik Heart Recent Development Table 79. CARMAT Company Information Table 80. CARMAT Business Overview Table 81. CARMAT Total Artificial Heart Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. CARMAT Total Artificial Heart Product Portfolio Table 83. CARMAT Recent Development Table 84. AbioMed Company Information Table 85. AbioMed Business Overview Table 86. AbioMed Total Artificial Heart Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. AbioMed Total Artificial Heart Product Portfolio Table 88. AbioMed Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Total Artificial Heart Distributors List Table 92. Total Artificial Heart Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Total Artificial Heart Product Image Figure 2. Global Total Artificial Heart Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Total Artificial Heart Sales Value (2021-2032) & (US$ Million) Figure 4. Global Total Artificial Heart Sales (2021-2032) & (Units) Figure 5. Global Total Artificial Heart Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Total Artificial Heart Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. SynCardia Image Figure 10. Others Image Figure 11. Global Total Artificial Heart Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Total Artificial Heart Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Total Artificial Heart Sales Volume Share by Type (2021-2032) Figure 14. Global Total Artificial Heart Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Total Artificial Heart Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Total Artificial Heart Sales Value Share by Type (2021-2032) Figure 17. Dilated Cardiomyopathy Image Figure 18. Ischemic Cardiomyopathy Image Figure 19. Others Image Figure 20. Global Total Artificial Heart Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 21. Global Total Artificial Heart Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Total Artificial Heart Sales Volume Share by Application (2021-2032) Figure 23. Global Total Artificial Heart Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Total Artificial Heart Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Total Artificial Heart Sales Value Share by Application (2021-2032) Figure 26. Global Total Artificial Heart Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 27. Global Total Artificial Heart Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Total Artificial Heart Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Total Artificial Heart Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Total Artificial Heart Sales Value (2021-2032) & (US$ Million) Figure 31. North America Total Artificial Heart Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Total Artificial Heart Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Total Artificial Heart Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Total Artificial Heart Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Total Artificial Heart Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Total Artificial Heart Sales Value (2021-2032) & (US$ Million) Figure 37. South America Total Artificial Heart Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Total Artificial Heart Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Total Artificial Heart Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Total Artificial Heart Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Total Artificial Heart Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Total Artificial Heart Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Total Artificial Heart Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Total Artificial Heart Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • SynCardia
  • Others
Applications
  • Dilated Cardiomyopathy
  • Ischemic Cardiomyopathy
  • Others
Companies covered
  • BiVACOR
  • SynCardia
  • Jarvik Heart
  • CARMAT
  • AbioMed

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Total Artificial Heart Sales Value (2021-2032)
  4. 1.2.2 Global Total Artificial Heart Sales Volume (2021-2032)
  5. 1.2.3 Global Total Artificial Heart Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Total Artificial Heart Market Dynamics
  1. 2.1 Total Artificial Heart Industry Trends
  2. 2.2 Total Artificial Heart Industry Drivers
  3. 2.3 Total Artificial Heart Industry Opportunities and Challenges
  4. 2.4 Total Artificial Heart Industry Restraints
3 Total Artificial Heart Market by Company
  1. 3.1 Global Total Artificial Heart Company Revenue Ranking in 2025
  2. 3.2 Global Total Artificial Heart Revenue by Company (2021-2026)
  3. 3.3 Global Total Artificial Heart Sales Volume by Company (2021-2026)
  4. 3.4 Global Total Artificial Heart Average Price by Company (2021-2026)
  5. 3.5 Global Total Artificial Heart Company Ranking (2024-2026)
  6. 3.6 Global Total Artificial Heart Company Manufacturing Base and Headquarters
  7. 3.7 Global Total Artificial Heart Company Product Type and Application
  8. 3.8 Global Total Artificial Heart Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Total Artificial Heart Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Total Artificial Heart Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Total Artificial Heart Market by Type
  1. 4.1 Total Artificial Heart Type Introduction
  2. 4.1.1 SynCardia
  3. 4.1.2 Others
  4. 4.2 Global Total Artificial Heart Sales Volume by Type
  5. 4.2.1 Global Total Artificial Heart Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Total Artificial Heart Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Total Artificial Heart Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Total Artificial Heart Sales Value by Type
  9. 4.3.1 Global Total Artificial Heart Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Total Artificial Heart Sales Value by Type (2021-2032)
  11. 4.3.3 Global Total Artificial Heart Sales Value Share by Type (2021-2032)
5 Total Artificial Heart Market by Application
  1. 5.1 Total Artificial Heart Application Introduction
  2. 5.1.1 Dilated Cardiomyopathy
  3. 5.1.2 Ischemic Cardiomyopathy
  4. 5.1.3 Others
  5. 5.2 Global Total Artificial Heart Sales Volume by Application
  6. 5.2.1 Global Total Artificial Heart Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Total Artificial Heart Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Total Artificial Heart Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Total Artificial Heart Sales Value by Application
  10. 5.3.1 Global Total Artificial Heart Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Total Artificial Heart Sales Value by Application (2021-2032)
  12. 5.3.3 Global Total Artificial Heart Sales Value Share by Application (2021-2032)
6 Total Artificial Heart Regional Sales and Value Analysis
  1. 6.1 Global Total Artificial Heart Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Total Artificial Heart Sales by Region (2021-2032)
  3. 6.2.1 Global Total Artificial Heart Sales by Region: 2021-2026
  4. 6.2.2 Global Total Artificial Heart Sales by Region (2027-2032)
  5. 6.3 Global Total Artificial Heart Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Total Artificial Heart Sales Value by Region (2021-2032)
  7. 6.4.1 Global Total Artificial Heart Sales Value by Region: 2021-2026
  8. 6.4.2 Global Total Artificial Heart Sales Value by Region (2027-2032)
  9. 6.5 Global Total Artificial Heart Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Total Artificial Heart Sales Value (2021-2032)
  12. 6.6.2 North America Total Artificial Heart Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Total Artificial Heart Sales Value (2021-2032)
  15. 6.7.2 Europe Total Artificial Heart Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Total Artificial Heart Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Total Artificial Heart Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Total Artificial Heart Sales Value (2021-2032)
  21. 6.9.2 South America Total Artificial Heart Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Total Artificial Heart Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Total Artificial Heart Sales Value Share by Country, 2025 VS 2032
7 Total Artificial Heart Country-level Sales and Value Analysis
  1. 7.1 Global Total Artificial Heart Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Total Artificial Heart Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Total Artificial Heart Sales by Country (2021-2032)
  4. 7.3.1 Global Total Artificial Heart Sales by Country (2021-2026)
  5. 7.3.2 Global Total Artificial Heart Sales by Country (2027-2032)
  6. 7.4 Global Total Artificial Heart Sales Value by Country (2021-2032)
  7. 7.4.1 Global Total Artificial Heart Sales Value by Country (2021-2026)
  8. 7.4.2 Global Total Artificial Heart Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Total Artificial Heart Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Total Artificial Heart Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Total Artificial Heart Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Total Artificial Heart Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Total Artificial Heart Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Total Artificial Heart Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Total Artificial Heart Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Total Artificial Heart Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Total Artificial Heart Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Total Artificial Heart Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Total Artificial Heart Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Total Artificial Heart Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Total Artificial Heart Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Total Artificial Heart Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Total Artificial Heart Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Total Artificial Heart Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Total Artificial Heart Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Total Artificial Heart Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Total Artificial Heart Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Total Artificial Heart Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Total Artificial Heart Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Total Artificial Heart Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Total Artificial Heart Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Total Artificial Heart Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Total Artificial Heart Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Total Artificial Heart Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Total Artificial Heart Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Total Artificial Heart Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Total Artificial Heart Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Total Artificial Heart Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BiVACOR
  2. 8.1.1 BiVACOR Company Information
  3. 8.1.2 BiVACOR Business Overview
  4. 8.1.3 BiVACOR Total Artificial Heart Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BiVACOR Total Artificial Heart Product Portfolio
  6. 8.1.5 BiVACOR Recent Developments
  7. 8.2 SynCardia
  8. 8.2.1 SynCardia Company Information
  9. 8.2.2 SynCardia Business Overview
  10. 8.2.3 SynCardia Total Artificial Heart Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 SynCardia Total Artificial Heart Product Portfolio
  12. 8.2.5 SynCardia Recent Developments
  13. 8.3 Jarvik Heart
  14. 8.3.1 Jarvik Heart Company Information
  15. 8.3.2 Jarvik Heart Business Overview
  16. 8.3.3 Jarvik Heart Total Artificial Heart Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Jarvik Heart Total Artificial Heart Product Portfolio
  18. 8.3.5 Jarvik Heart Recent Developments
  19. 8.4 CARMAT
  20. 8.4.1 CARMAT Company Information
  21. 8.4.2 CARMAT Business Overview
  22. 8.4.3 CARMAT Total Artificial Heart Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 CARMAT Total Artificial Heart Product Portfolio
  24. 8.4.5 CARMAT Recent Developments
  25. 8.5 AbioMed
  26. 8.5.1 AbioMed Company Information
  27. 8.5.2 AbioMed Business Overview
  28. 8.5.3 AbioMed Total Artificial Heart Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 AbioMed Total Artificial Heart Product Portfolio
  30. 8.5.5 AbioMed Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Total Artificial Heart Value Chain Analysis
  2. 9.1.1 Total Artificial Heart Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Total Artificial Heart Sales Mode & Process
  6. 9.2 Total Artificial Heart Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Total Artificial Heart Distributors
  9. 9.2.3 Total Artificial Heart Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst